6 results match your criteria: "University of Queensland Thoracic Research Centre at The Prince Charles Hospital[Affiliation]"
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes.
Br J Cancer
January 2023
The Daffodil Centre, the University of Sydney, A joint venture with Cancer Council NSW, Sydney, NSW, Australia.
Background: A national, lung cancer screening programme is under consideration in Australia, and we assessed cost-effectiveness using updated data and assumptions.
Methods: We estimated the cost-effectiveness of lung screening by applying screening parameters and outcomes from either the National Lung Screening Trial (NLST) or the NEderlands-Leuvens Longkanker Screenings ONderzoek (NELSON) to Australian data on lung cancer risk, mortality, health-system costs, and smoking trends using a deterministic, multi-cohort model. Incremental cost-effectiveness ratios (ICERs) were calculated for a lifetime horizon.
Air pollution in the Asia-Pacific Region: A Joint Asian Pacific Society of Respirology/American Thoracic Society perspective (Republication).
Respirology
May 2019
The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia.
Air Pollution in the Asia-Pacific Region. A Joint Asian Pacific Society of Respirology/American Thoracic Society Perspective.
Am J Respir Crit Care Med
March 2019
15 The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, Australia; and.
Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
J Thorac Oncol
August 2018
Cancer Research Division, Cancer Council New South Wales, New South Wales, Australia; School of Public Health, University of Sydney, New South Wales, Australia; Prince of Wales Clinical School, University of New South Wales, New South Wales, Australia.
Introduction: Health economic evaluations of lung cancer screening with low-dose computed tomography (LDCT) that are underpinned by clinical outcomes are relatively few.
Methods: We assessed the cost-effectiveness of LDCT lung screening in Australia by applying Australian cost and survival data to the outcomes observed in the U.S.
Genomics of lung cancer.
J Thorac Dis
February 2017
University of Queensland Thoracic Research Centre at the Prince Charles Hospital, Brisbane, Australia.